Vesti Intelligence Corp. Releases CaptoMe, a New Platform to Mine, Manage, and Share Scientific Information

Share Article

Vesti Intelligence Corp offers eL7 Technology platform with a single integrated workspace environment for “ReSearch, Discover, and Share” in drug development and associate biomedical research.

CaptoMe - Become an Expert

Using CaptoMe is like having a personal research assistant that helps one to stay focused on research while making your work consistently organized and up-to-date.

Vesti Intelligence Corp. is pleased to announce the release of CaptoMe, a new web-based application that benefits researchers and business professionals in pharmaceutical and biotech industry. CaptoMe addresses three main challenges of modern research: data deluge, data silos, and research cost. It does so by offering users a single integrated workspace with access to standardized and integrated federated search of rich and customizable content. A summary of curated domain-specific data is instantly displayed for quick assessment of the domain status per each search term. In conjunction with record management tools, dynamic sharing, and report generation capabilities, CaptoMe is a premier tool for highly specific biomedical expertise advancement in an efficient, accurate and up-to-date manner.

Vesti’s proprietary eL7 noetic processor automatically curates and continuously updates biomedical data from 5 public sources (Publications, Clinical Trials, Patents, Conference Abstracts, and Biomedical News). Federated search results are first presented in the cS3 summary table, organized by domain- specific categories. The learning machine algorithm used by the eL7 processor, provides an additional level of confidence and information query optimization when the search pattern becomes recognizable by the machine after a few months of regular use. Overall, CaptoMe helps facilitate research optimization and boost innovation.

“I am very optimistic that this tool will become a common tool among scientists and decision makers in research and drug discovery areas. Using CaptoMe is like having a personal research assistant that helps one to stay focused on research while making your work consistently organized and up-to-date. I wish I had this tool when I was doing my due diligence in drug discovery research” says Dr Palaniyandi Manivasakam, Chief Scientific Officer of Vesti Intelligence Corp.

While the eL7 and cS3 systems do the heavy work, each user can enjoy the “PRO” workspace feature, which allows them to build a research project (acquire, manage, and record findings) from within one screen. Upcoming new options in CaptoMe include allowing the selection of publication for full text purchasing, sharing user’s expertise with a selected team of CaptoMe users, and allowing the assignment of projects to other users at different levels of project completion. CaptoMe is offered free of charge* with basic features in Cell Biology domain. To learn more about CaptoMe - view demo or simply register at http://www.captome.com and start using it today!

About Vesti Intelligence Corp.
Vesti Intelligence Corp. is a company that offers innovative technology platform with first-rate biomedical intelligence and management tools for customers who desire to accelerate their decision-making processes, to boost innovation and productivity in preclinical drug development, research and related services.

For further information please contact
Dr. Irina I. Agoulnik
Chief Executive Officer
Vesti Intelligence Corp.
Email: i.agoulnik(at)vesticorp(dot)com

  • Some restrictions may apply

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Irina Agoulnik

Victor Kalimuthu
Vesti Intelligence Corp
6176376964
Email >
Visit website